Sylvia Joanna Degrado

Title: Sylvia Joanna Degrado: Innovator in Pharmaceutical Compounds

Introduction

Sylvia Joanna Degrado is a prominent inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of 5 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents, one invention is directed to compounds of generic formula I, or pharmaceutically acceptable salts thereof, believed to be useful as an A2A-receptor antagonist. Another notable invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), along with their pharmaceutically acceptable salts. This invention also includes pharmaceutical compositions comprising such compounds and methods for treating diseases associated with uncontrolled or inappropriate stimulation of CRTH function.

Career Highlights

Throughout her career, Sylvia has worked with renowned companies such as Merck Sharp & Dohme Corporation and Schering Corporation. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and contribute to significant advancements in the field.

Collaborations

Some of her notable coworkers include Dong Xiao and Anandan Palani, with whom she has collaborated on various projects aimed at enhancing pharmaceutical research and development.

Conclusion

Sylvia Joanna Degrado's contributions to pharmaceutical innovations demonstrate her commitment to advancing medical science. Her patents reflect her expertise and dedication to improving health outcomes through targeted therapies.